Related Experiment Videos
Abstract:
The author reports on self-experienced, reboxetine-induced sexual dysfunction (prolonged orgasm of reduced intensity) and seminal emission after defecation. Both disorders were accompanied by pain and ceased within two days after discontinuation of the drug.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Patient knowledge regarding tardive dyskinesia].
Der Nervenarzt·2006
Spontaneous remission of SSRI-induced orgasm delay.
Pharmacopsychiatry·2004
[Neuroleptic treatment by the established psychiatrist. A report of experiences].
Psychiatrische Praxis·1999
Pipamperone metabolism by various recombinant cytochrome preparations.
Pharmacopsychiatry·2026
Lithium Prescription in Unipolar Depression: Findings from a Nationwide Greek Cohort Study.
Pharmacopsychiatry·2026
Sedative-hypnotic properties and mitochondrial effects of coenzyme Q2 in mice.
Current molecular pharmacology·2026
Trends in Medicines Discontinuation and Implications for Access in Brazil (2014-2024).
Pharmacoepidemiology and drug safety·2026
Carabrone alleviates neuroinflammation by covalently targeting ubiquitin conjugating enzyme UBE2D3 in experimental autoimmune encephalomyelitis.
European journal of pharmacology·2026
Emergency department diagnosis and management of acetaminophen or salicylate toxicity.
Emergency medicine practice·2026
Reduced Codeine Analgesic Efficacy Associated with Nicardipine in a Patient with Medication-Overuse Headache: A Case Report.
Journal of pain & palliative care pharmacotherapy·2026